BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38336557)

  • 1. A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using
    Lee YC; Nik Akhtar M; Kim Y; Jung JW
    Brachytherapy; 2024; 23(3):377-386. PubMed ID: 38336557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
    Lee YC; Lin SC; Kim Y
    Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optic disc dose reduction in ocular brachytherapy using
    Lee YC; Lin SC; Kim Y
    J Appl Clin Med Phys; 2020 Sep; 21(9):57-70. PubMed ID: 32656945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic Disc Dose Comparison Between 125I and 103Pd Collaborative Ocular Melanoma Study (COMS) Plaques Based on Current Clinical Practice.
    Lee YC; Lin SC; Kim Y
    Cureus; 2021 Jun; 13(6):e15980. PubMed ID: 34336471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dose calculation methods for brachytherapy of intraocular tumors.
    Rivard MJ; Chiu-Tsao ST; Finger PT; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Rogers DW; Thomson RM; Nath R
    Med Phys; 2011 Jan; 38(1):306-16. PubMed ID: 21361199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
    Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
    J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous dose calculations for Collaborative Ocular Melanoma Study eye plaques using actual seed configurations and Task Group Report 43 formalism.
    Deufel CL; Furutani KM
    Brachytherapy; 2015; 14(2):209-30. PubMed ID: 25533415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
    Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
    Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities.
    Das RK; Keleti D; Zhu Y; Kirov AS; Meigooni AS; Williamson JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):843-53. PubMed ID: 9240654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo dosimetry for I125 and Pd103 eye plaque brachytherapy.
    Thomson RM; Taylor REP; Rogers DWO
    Med Phys; 2008 Dec; 35(12):5530-5543. PubMed ID: 28525130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMS eye plaque brachytherapy dosimetry simulations for P103d, I125, and C131s.
    Melhus CS; Rivard MJ
    Med Phys; 2008 Jul; 35(7Part1):3364-3371. PubMed ID: 28513032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalent uniform RBE-weighted dose in eye plaque brachytherapy.
    Chvetsov AV
    Med Phys; 2024 Apr; 51(4):3093-3100. PubMed ID: 38353266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of the CLRP eye plaque brachytherapy database for photon-emitting sources.
    Safigholi H; Parsons Z; Deering SG; Thomson RM
    Med Phys; 2021 Jun; 48(6):3373-3283. PubMed ID: 33735471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.